Neovantage Innovation Parks

What Neovantage Innovation Parks does

Neovantage Innovation Parks is a privately held real estate infrastructure platform that develops, owns, and operates purpose-built laboratory and R&D office space for life sciences companies. Founded in 2016 and headquartered in Genome Valley, Hyderabad, India, the company operates four campuses — GV Innovation Center, GV Innovation Center II, Biotech Research Park, and Knowledge Square Park — comprising 12 buildings totaling approximately 1.4 million square feet with reported occupancy above 95% across more than 40 tenants spanning global pharmaceutical firms, biotech companies, vaccine manufacturers, contract research organizations (CROs), and contract development and manufacturing organizations (CDMOs). Since July 2021, the portfolio has been owned and operated through an 80:20 joint venture between Ivanhoé Cambridge — the global real estate subsidiary of CDPQ (Caisse de dépôt et placement du Québec) — and Lighthouse Canton.

The company's core product is a portfolio of LEED Gold and Platinum certified multi-tenanted and build-to-suit facilities engineered for wet labs, dry labs, chemistry, biology, formulation, and agri-tech workflows. Buildings feature centralized MEP shafts, overhead service highways, chilled water systems, compressed air, vacuum systems, specialty gases, Building Management Systems, VAV-controlled HVAC with dynamic air change rates, directional airflow provisions for fume hoods and biosafety cabinets, 100% power backup, on-site ETP/STP for hazardous waste handling, and GMP-compliant environments supporting biopharmaceutical production. Neovantage complements the physical infrastructure with facility management, project management, and design optimization services, and supports amenity infrastructure including fire response, medical, banking, dining, and conferencing.

The revenue model is enterprise B2B real estate leasing on multi-year contracts, combining speculative multi-tenanted buildings with custom build-to-suit developments. Pricing is negotiated per square foot based on building, floor area, fit-out requirements, and lease term, and is not publicly disclosed. Distribution is direct via an enterprise field sales team, supplemented by event-driven engagement at industry conferences such as BioAsia (where Neovantage is Industry Co-Host for 2026) and CPHI Frankfurt 2025, and by hosting international governmental and industry delegations at the Genome Valley campus. Capital access was reinforced in September 2024 with an INR 300 crore (~USD 36M) green loan from HSBC India — the bank's first green loan in India's life sciences real estate sector — refinancing existing debt on the basis of the portfolio's LEED, GRESB, and WELL certifications and its track record of carbon-neutral operations in 2020 and 2021.

Name

Neovantage Innovation Parks

Legal name

Neovantage Innovation Parks

Website

https://neovantage-parks.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Neovantage Innovation Parks is a Hyderabad-based private real estate infrastructure platform operating 1.4 million square feet of LEED-certified laboratory and R&D office space across four Genome Valley campuses, leasing to pharmaceutical, biotech, vaccine, CRO, and CDMO tenants.

Ownership category

akta.pro rank

Product category

Life Sciences R&D Real Estate

NAICS

Other Specialized Design Services (54149)

SIC

Services-Facilities Support Management Services (8744)

akta.pro primary industry

Life Sciences/Laboratory Property Management (BPAJAGAL)

akta.pro secondary industry

Lab Furniture, Facilities & Utilities (Benches, Casework, Gas/Water Systems) (HLAGAIAM)

Keywords

• Life sciences real estate
• Laboratory leasing services
• Pharmaceutical R&D infrastructure
• Biotech research facilities
• GMP-compliant lab spaces

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Infrastructure, Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Life Sciences Real Estate Leasing: Neovantage Innovation Parks generates revenue primarily through leasing specialized laboratory, R&D office, and support infrastructure spaces to life sciences companies. The portfolio includes both multi-tenanted buildings and build-to-suit facilities. Leasing models include multi-tenanted speculative projects and custom-designed build-to-suit developments for companies with specialized R&D, manufacturing, or testing requirements.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Core offering

Neovantage Innovation Parks develops, owns, and operates a portfolio of purpose-built laboratory and office campuses within Genome Valley, Hyderabad, India, leasing specialized wet-lab, dry-lab, formulation, and GMP-compliant R&D spaces to pharmaceutical, biotechnology, vaccine, CRO, and CDMO companies. It also delivers integrated facilities management, project management, and design optimization services covering end-to-end life sciences infrastructure needs.

Product overview

Neovantage Innovation Parks is South Asia's largest private owner and operator of leasable Life Sciences infrastructure, offering a portfolio of sustainably designed and managed buildings across four campuses (GV Innovation Center, GV Innovation Center II, Biotech Research Park, and Knowledge Square Park) in Genome Valley, Hyderabad. The company provides comprehensive real estate solutions including multi-tenanted and build-to-suit laboratory and R&D spaces, supported by Facilities Management, Project Management, Design Optimization, and Space Planning services. Their buildings are LEED certified (Gold and Platinum), feature world-class amenities, and cater to pharmaceutical R&D, vaccine development, biotechnology research, CROs, and biopharma production sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• GV Innovation Center
• GV Innovation Center II
• Biotech Research Park
• Knowledge Square Park
• Facilities Management
• Project Management
• Design Optimization
• Amenities

Quantifiable outcome

• 95%+ occupancy rate across 1.4 million sq ft portfolio
• +4 more outcomes

Named customers16 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Miltenyi BioteccoreStrategic or Co-development Partner · 3 March 2025Miltenyi Biotec inaugurated its Miltenyi Innovation and Technology Center, a Cell and Gene Therapy (CGT) Centre of Excellence (COE), at Neovantage Innovation Parks in March 2025. This is the first facility of its kind in India for cutting-edge cell and gene therapy research and manufacturing. The inauguration represents a major milestone in India's journey toward advanced biopharmaceutical innovation. Dr. Boris Stoffel, CEO of Miltenyi Biotech, and Ms. Priya Hingorani, Managing Director of Miltenyi Biotec India, led the inauguration ceremony.

Scale indicators9 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Breakthrough Properties: Breakthrough is a joint venture between Tishman Speyer and Ivanhoé Cambridge developing life sciences campuses in gateway innovation markets. Notably, it shares the Ivanhoé Cambridge sponsorship with Neovantage and pursues a comparable build-to-suit and multi-tenant lab strategy.
• Kadans Science Partner: Kadans is a European specialist in life sciences real estate operating multi-tenant lab and innovation campuses across the UK, Netherlands, Germany, Belgium, and France. Directly comparable in providing purpose-built wet lab/dry lab infrastructure to life sciences tenants in innovation clusters.
• Healthpeak Properties: Healthpeak owns the legacy BioMed Realty life sciences portfolio — a major owner of Class A life sciences campuses on the US coasts. Directly comparable to Neovantage in providing multi-tenant lab/R&D infrastructure to pharma and biotech tenants.
• Wexford Science & Technology: Wexford develops and operates knowledge communities and life sciences buildings, often in partnership with universities and health systems. Comparable in providing purpose-built research and innovation infrastructure anchored in established academic/medical clusters.
• IQHQ: IQHQ was a US life sciences REIT focused on premium lab/office assets in coastal innovation markets (now part of Healthpeak). Comparable to Neovantage in delivering high-quality, sustainable, multi-tenant life sciences infrastructure in leading clusters.
• Alexandria Real Estate Equities: Alexandria is the largest US-listed REIT focused exclusively on life sciences office/lab space. It is the most direct global comparable to Neovantage given its mission-built, multi-tenant lab facilities leased to pharma/biotech tenants.
• Longfellow Real Estate Partners: Longfellow is a US-based owner/developer focused exclusively on life sciences and technology campuses. Comparable to Neovantage in its mission-built lab/R&D facilities and cluster-focused strategy in innovation hubs.

Broad incumbents

• Trammell Crow Company: Trammell Crow is a major US commercial developer with an active life sciences development practice, including build-to-suit lab and biomanufacturing facilities. Comparable as a broad incumbent developer active in the same space.
• BGO Real Estate: BGO is a global real estate investment manager with a significant life sciences platform (including legacy Bentall Kennedy). It is comparable as a broad incumbent with overlapping capabilities, though its portfolio spans many asset classes beyond life sciences.

Regional players

• CapitaLand (India life sciences): CapitaLand operates large-scale business parks and innovation campuses in India (through its Ascott/Ascendas heritage). While not exclusively a life sciences landlord, its Indian parks host life sciences tenants and represent a regional comparable in purpose-built innovation real estate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neovantage Innovation Parks